Volume 21, Issue 2 (Summer 2024)
Sci J Iran Blood Transfus Organ 2024, 21(2): 129-137 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zadsar M, Chegini A, Rnjbar kermani F. Comparison between the amount of request and distribution of blood and its products to hospitals, before and at the time of Covid-19 pandemic. Sci J Iran Blood Transfus Organ 2024; 21 (2) :129-137
URL: http://bloodjournal.ir/article-1-1528-en.html
URL: http://bloodjournal.ir/article-1-1528-en.html
Full-Text [PDF 412 kb]
(244 Downloads)
| Abstract (HTML) (938 Views)
Full-Text: (210 Views)
References:
Comparison between the amount of request and
distribution of blood and its products to hospitals,
before and at the time of Covid-19 pandemic
Zadsar M.1, Chegini A.1, Ranjbar Kermani F.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
Covid-19 was declared a public health emergency by World Health Organization in jan 2020. Public fear, quarantine, and shutdown created an unpredictable situation for healthcare services worldwide, which created a great challenge for blood transfusion services.
Materials and Methods
In a cross-sectional study, the data about the request, distribution, and waste of blood products were collected and compared in two time periods (March and February 2019 and March and February 2020) before and at the time or Covid-19 pandemic with test of proportion. The poisson regression test was used to compare the amount of waste, request, and distribution of blood products in two consecutive years.
Results
The request for red blood cells before the pandemic was 920,591 units, but it decreased by 18% to 754,052 units, and the distribution of red blood cells decreased by 17.3% at the time of pandemic, because of the cancellation of surgeries and general quarantine. The RBC wastage decreased from 25878 to 12837 units, a reduction of 50.3% (p = 0.03). However, the demand for leukoreduced red blood cells rose by 10.8%, yet wastage also increased by 8.8%. Waste in red blood cell bags for infants quadrupled during the pandemic. Plasma requests decreased by 4.9%, with a 7.2% decline in distribution, yet plasma waste increased by 6.8%. At pandemic time, Platelet requests decreased by 19%, distribution decreased by 15.6%, and waste decreased by 32.3%.
Conclusions
During the COVID-19 pandemic, the waste of RBCs and platelets was reduced. The distribution-to-demand ratio remained relatively stable throughout the pandemic time.
Key words: COVID-19 Pandemic, Blood Component Transfusion, Hospitals
Received: 21 Feb 2024
Accepted:12 Jun 2024
Correspondence: Chegini A., MD. Specialist in Anesthesiology. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052256; Fax: (+9821) 88601599
E-mail: a.chegini@ibto.ir
- WHO. World Health Organization. Rolling updates on coronavirus disease (COVID-19); 2019. Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
- Yahia AIO. Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia. Transfus Apher Sci 2020; 59(5): 102836.
- Shander A, Goobie SM, Warner MA, Aapro M, Bisbe E, Perez-Calatayud AA, et al. Essential role of patient blood management in a pandemic: a call for action. Anesth Analg 2020; 131(1): 74-85.
- Gschwender AN, Gillard L. Disaster preparedness in the blood bank. American Society for Clinical Laboratory Scienc 2017; 30(4): 250-7.
- Shan H, Zhang P. Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing. Transfusion 2004; 44(4): 467-9.
- Arcot PJ, Kumar K, Mukhopadhyay T, Subramanian A. Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario. Transfus Apher Sci 2020; 59(5): 102877.
- Dhiman Y, Patidar GK, Arora S. Covid‐19 pandemic‐response to challenges by blood transfusion services in India: a review report. ISBT Science Series 2020; 15(4): 365-73.
- Loua A, Kasilo OMJ, Nikiema JB, Sougou AS, Kniazkov S, Annan EA. Impact of the COVID‐19 pandemic on blood supply and demand in the WHO African region. Vox Sang 2021; 116(7): 774-84.
- Yazer MH, Jackson B, Pagano M, Rahimi‐Levene N, Peer V, Bueno JL, et al. Vox Sanguinis international forum on transfusion services' response to COVID‐19: summary. Vox Sang 2020; 115(6): 536.
- Franchini M, Farrugia A, Velati C, Zanetti A, Romanò L, Grazzini G, et al. The impact of the SARS‐CoV‐2 outbreak on the safety and availability of blood transfusions in Italy. Vox Sang 2020; 115(8): 603.
- Balagholi S, Maghsudlu M, Amini-Kafiabad S, Nazemi AM, Anvari MS. COVID-19 related callback in blood donors; outcomes in blood donors and patients. Transfus Apher Sci 2021; 60(4): 103129.
- Cai X, Ren M, Chen F, Li L, Lei H, Wang X. Blood transfusion during the COVID-19 outbreak. Blood Transfus 2020; 18(2): 79.
- Fan BE, Ong KH, Chan SSW, Young BE, Chong VCL, Chen SPC, et al. Blood and blood product use during COVID‐19 infection. Am J Hematol 2020; 95(7): E158.
- Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020; 7(10): e756-e64.
- Nguyen A, Burnett-Greenup S, Riddle D, Enderle J, Carman C, Rajendran R. Blood usage and wastage at an academic teaching hospital before the initial wave of COVID-19 and during and after its quarantine periods. Lab Med 2024; 55(2): 198-203.
- Trivella M, Stanworth SJ, Brunskill S, Dutton P, Altman DG. Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes? BMJ 2019; 365:l2320.
- Stolla M, Fitzpatrick L, Gettinger I, Bailey SL, Pellham E, Christoffel T, et al. In vivo viability of extended 4° C‐stored autologous apheresis platelets. Transfusion
2018; 58(10): 2407-13. - Chegini A. Evaluating the importance of patient blood management during COVID-19 pandemic. Anesth Pain Med 2022; 11(6): e112910.
- Murphy MF, Waters JH, Wood EM, Yazer MH. Transfusing blood safely and appropriately. BMJ 2013; 347: f4303.
- Dunbar NM, Yazer MH, Collaborative BEfST, Investigators tSS, Carey PM, Christie JD, et al. Safety of the use of group A plasma in trauma: the STAT study. Transfusion 2017; 57(8): 1879-84.
- Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al. Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA 2019; 321(10): 983-97.
- Desborough MJ, Oakland K, Brierley C, Bennett S, Doree C, Trivella M, et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database Syst Rev 2017; 7(7): CD001884.
|
Sci J Iran Blood Transfus Organ 2024;22 (2): 129-137 |
|
Original Article
|
distribution of blood and its products to hospitals,
before and at the time of Covid-19 pandemic
Zadsar M.1, Chegini A.1, Ranjbar Kermani F.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
Covid-19 was declared a public health emergency by World Health Organization in jan 2020. Public fear, quarantine, and shutdown created an unpredictable situation for healthcare services worldwide, which created a great challenge for blood transfusion services.
Materials and Methods
In a cross-sectional study, the data about the request, distribution, and waste of blood products were collected and compared in two time periods (March and February 2019 and March and February 2020) before and at the time or Covid-19 pandemic with test of proportion. The poisson regression test was used to compare the amount of waste, request, and distribution of blood products in two consecutive years.
Results
The request for red blood cells before the pandemic was 920,591 units, but it decreased by 18% to 754,052 units, and the distribution of red blood cells decreased by 17.3% at the time of pandemic, because of the cancellation of surgeries and general quarantine. The RBC wastage decreased from 25878 to 12837 units, a reduction of 50.3% (p = 0.03). However, the demand for leukoreduced red blood cells rose by 10.8%, yet wastage also increased by 8.8%. Waste in red blood cell bags for infants quadrupled during the pandemic. Plasma requests decreased by 4.9%, with a 7.2% decline in distribution, yet plasma waste increased by 6.8%. At pandemic time, Platelet requests decreased by 19%, distribution decreased by 15.6%, and waste decreased by 32.3%.
Conclusions
During the COVID-19 pandemic, the waste of RBCs and platelets was reduced. The distribution-to-demand ratio remained relatively stable throughout the pandemic time.
Key words: COVID-19 Pandemic, Blood Component Transfusion, Hospitals
Received: 21 Feb 2024
Accepted:12 Jun 2024
Correspondence: Chegini A., MD. Specialist in Anesthesiology. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052256; Fax: (+9821) 88601599
E-mail: a.chegini@ibto.ir
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
